Bridge City Capital LLC Sells 14,197 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Bridge City Capital LLC reduced its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 21.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 50,750 shares of the company's stock after selling 14,197 shares during the period. Bridge City Capital LLC owned about 0.33% of U.S. Physical Therapy worth $3,672,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in U.S. Physical Therapy by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company's stock valued at $96,179,000 after buying an additional 6,393 shares during the last quarter. Southernsun Asset Management LLC increased its holdings in U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock valued at $50,725,000 after buying an additional 24,698 shares during the period. Dimensional Fund Advisors LP increased its holdings in U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock valued at $37,818,000 after buying an additional 7,890 shares during the period. Envestnet Asset Management Inc. raised its position in shares of U.S. Physical Therapy by 20.1% in the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock valued at $26,594,000 after buying an additional 50,163 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of U.S. Physical Therapy by 13.9% during the 4th quarter. Northern Trust Corp now owns 261,825 shares of the company's stock worth $23,226,000 after buying an additional 32,024 shares during the last quarter.

U.S. Physical Therapy Stock Down 0.1%

USPH stock traded down $0.10 during mid-day trading on Thursday, reaching $78.06. 393,266 shares of the company traded hands, compared to its average volume of 115,656. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 83.04, a P/E/G ratio of 3.54 and a beta of 1.45. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20. The firm's 50 day moving average price is $72.84 and its 200 day moving average price is $81.81. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.51 earnings per share. As a group, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.31%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of research analyst reports. JMP Securities reiterated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. JPMorgan Chase & Co. dropped their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, Barrington Research decreased their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.